Angiotensin converting enzyme inhibitor potentiated the vasorelaxant response of atrial natriuretic peptide in toad aortic rings

Berman, 1989, Effect of atrial natriuretic peptide on amphibian skin, Arch. Int. Physiol. Biochem., 97, 63 Bianchi, 1985, Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues, Histochemistry, 82, 441, 10.1007/BF02450479 Briggs, 1984, Inactivation of atrial natriuretic substance by kallikrein, Am. J. Physiol., 247, F480 Cantin, 1979, Ultrastructural cytochemistry ofatrial muscle cells. VI. Comparative study of specific granules in right and left atrium of various animal species, Anat. Rec., 193, 55, 10.1002/ar.1091930105 Cantin, 1987, Immunoreactive atrial natriuretic factor is present in both atria and ventricles, Molec. Cell. Endocr., 52, 105, 10.1016/0303-7207(87)90103-1 Coviello, 1989, Effect of cardionatrin I (rat ANE 99–126) on the response of toad skin to angiotensin II, Can. J. Physiol. Pharmacol., 67, 362, 10.1139/y89-058 Currie, 1983, Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria, Science, 221, 71, 10.1126/science.6857267 de Bold, 1983, Tissue fractionation on the relationship between an atrial natriuretic factor and specific atrial granules, Can. J. Physiol. Pharmacol., 60, 324, 10.1139/y82-045 de Bold, 1986, Atrial natriuretic factor: an overview, 45, 2081 de Bold, 1983, Natriuretic activity of extracts obtained from hearts of different species and from various rat tissues, Can. J. Physiol. Pharmacol., 61, 127, 10.1139/y83-018 DeLean, 1985, Structure activity of atrial natriuretic factor (ANF). III. Correlation of receptor affinity with relative potency on aldosterone production m zona glomeruloza cells, Biochem. biophys. Res. Commun., 132, 360, 10.1016/0006-291X(85)91030-7 Erdos, 1975, Brief reviews: angiotensin I converting enzyme, Circ. Res., 36, 247, 10.1161/01.RES.36.2.247 Erdos, 1976, The Kinins: a status report, Biochem. Pharmacol., 25, 1563, 10.1016/0006-2952(76)90465-2 Fernández-Pardal, 1986, Angiotensin converting enzyme in the toad Bufo arenarum, Comp. Biochem. Physiol., 83A, 331, 10.1016/0300-9629(86)90584-0 Flynn, 1983, The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties, Biochem. biophys. Res. Commun., 117, 859, 10.1016/0006-291X(83)91675-3 Forssmann, 1986, Cardiac hormones. I. Review on the morphology, biochemistry and molecular biology of the endocrine heart, Eur. J. Clin. Invest., 16, 439, 10.1111/j.1365-2362.1986.tb02159.x Forssmann, 1984, Cardiac hormones: morphological and functional aspects, Hypertension, 6, 1873 Forssmann, 1983, The right auricule of the heart is an endocrine organ. Cariodilatin as a peptide hormone candidate, Anat. Embryol., 168, 303, 10.1007/BF00304269 Garcia, 1984, Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds, Am. J. Physiol., 247, R34 Gross, 1981, Effect of N|(S)-1-carboxy-3-phenyl-propil|-1-Ala-1-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor response in vivo, J. Pharmacol. exp. Ther., 216, 552 Hansell, 1987, Effect of atrial natriuretic peptide (ANP) during converting enzyme inhibition, Acta physiol. scand., 130, 393, 10.1111/j.1748-1716.1987.tb08154.x Harris, 1987, Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption, Nature, 326, 697, 10.1038/326697a0 Harris, 1985, Conversion of atriopeptin II to atriopeptide I by atrial dypeptidyl carboxy hydrolase, Peptide, 6, 393, 10.1016/0196-9781(85)90102-0 Igic, 1972, Clivage of active peptides by a lung enzyme, Experientia, 28, 135, 10.1007/BF01935713 Keatinge, 1966, Electrical and mechanical responses of vascular smooth muscle to vasodilator agents and vasoactive polypeptides, Circ. Res., 18, 641, 10.1161/01.RES.18.6.641 Kleinert, 1984, Atrial natriuretic factor inhibits angiotensin-norepinephrine and potassium-induced vascular contractility, Hypertension, 6, 1143, 10.1161/01.HYP.6.2_Pt_2.I143 Koehn, 1987, Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product, J. biol. Chem., 262, 11623, 10.1016/S0021-9258(18)60854-3 Krieter, 1989, Metabolism of atrial natriuretic peptide: extraction by organs in the rat, Drug Metab. Dispos., 17, 14 Luft, 1986, Atripeptin-III kinetics and pharmacodynamics in normal and anephric rats, J. Pharmacol. exp. Ther., 236, 416 Misono, 1984, Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity, Siochem. biophys. Res. Commun., 119, 524, 10.1016/S0006-291X(84)80279-X Napier, 1984, Specific membrane receptors for atrial natriuretic factor in renal and vascular tissue, 81, 5946 Olins, 1989, Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo, Molec. Cell. Endocr., 61, 201, 10.1016/0303-7207(89)90131-7 Patchett, 1980, A new class of angiotensin-converting enzyme inhibitors, Nature, 288, 280, 10.1038/288280a0 Peral de Bruno, 1988, Effets of angiotensin II in isolated toad Bufo arenarum aortic rings, Comp. Biochem. Physiol., 90C, 195 Saavedra, 1987, Alterations in atrial natriuretic peptide receptors in rat brain nuclei during hypertensiton and dehydration, Can. J. Physiol. Pharmacol., 66, 288, 10.1139/y88-049 Sakharov, 1988, Atriopeptin 2 is hydrolysed by cardiac but not pulmonary isozyme of angiotensin converting enzyme, Biochem. biophys. Res. Commun., 151, 109, 10.1016/0006-291X(88)90565-7 Salazar, 1985, Efecto de la angiotensina I en el transporte de sodio y agua, Rev. Argentina de Cardiologia, 53, 139 Schwartz, 1985, Ser-Leu-Arg-Arg-Atripeptin III: the major circulating form of atrial peptide, Science, 229, 397, 10.1126/science.3160114 Seymour, 1989, Potentiation of renal effects of atrial natriuretic factor-(99–126) by SQ 29,072, Hypertension, 14, 87, 10.1161/01.HYP.14.1.87 Sonnenberg, 1981, Cardiac atrial factor-an endogenous diuretic?, Can. J. Physiol. Pharmacol., 59, 1278, 10.1139/y81-200 Sonnenberg, 1988, Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney, Peptides, 9, 173, 10.1016/0196-9781(88)90024-1 Soria M., Proto M., Peral de Bruno M., Berman D., Coviello A., Khosla M. and Bumpus F. (198) Effects of angiotensin I of the american bullfrog Rana Catesbeiana on amphibian tissues. (Abstract) Acta Physiol. Pharmacol. Lat.38, 216–262. Stephenson, 1987, The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11, Biochem. J., 243, 183, 10.1042/bj2430183 Sugiyama, 1984, Synthesis of atrial natriuretic peptide and studies on structural factor in tissue specificity, Biochem. biophys. Res. Commun., 123, 338, 10.1016/0006-291X(84)90418-2 Vogt-Schaden, 1989, Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes, Biochem. biophys. Res. Commun., 161, 1177, 10.1016/0006-291X(89)91366-1 Wang, 1985, Renal response to atrial natriuretic factor during converting enzyme inhibition, Can. J. Physiol. Pharmacol., 63, 220, 10.1139/y85-041